Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway

Journal of Endocrinology

Volumn 214, Issue 3, 2012, Pages 437-443

  Geetha, Thangiah ^a,c   Langlais, Paul ^a   Caruso, Michael ^b   Yi, Zhengping ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 CATALYTIC SUBUNIT DELTA; PHOSPHOPROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 12A; PROTEIN KINASE B; PROTEIN P85; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; INSULIN SIGNALING PATHWAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CATALYTIC DOMAIN; CELLS, CULTURED; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MAP KINASE SIGNALING SYSTEM; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTO-ONCOGENE PROTEINS C-AKT; TOR SERINE-THREONINE KINASES;

EID: 84866296517     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0145     Document Type: Article

References (27)

1. Abdul-Ghani MA & DeFronzo RA 2010 Pathogenesis of insulin resistance in skeletal muscle. Journal of Biomedicine & Biotechnology 2010 476279.
2. Bollen M, PetiW, Ragusa MJ & Beullens M 2010 The extended PP1 toolkit: designed to create specificity. Trends in Biochemical Science 35 450-458.
3. Bouzakri K, Koistinen HA & Zierath JR 2005 Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes. Current Diabetes Reviews 1 167-174.
4. Castillo J, Ammendrup-Johnsen I, Codina M, Navarro I & Gutierrez J 2006 IGF-I and insulin receptor signal transduction in trout muscle cells. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 290 R1683-R1690.
5. Chao A, Zhang X, Ma D, Langlais P, Luo M, Mandarino LJ, Zingsheim M, Pham K, Dillon J & Yi Z 2012 Site-specific phosphorylation of protein phosphatase 1 regulatory subunit 12A stimulated or suppressed by insulin. Journal of Proteomics 75 3342-3350.
6. Codina M, de la Serrana DG, Sanchez-Gurmaches J, Montserrat N, Chistyakova O, Navarro I & Gutierrez J 2008 Metabolic and mitogenic effects of IGF-II in rainbow trout (Oncorhynchus mykiss) myocytes in culture and the role of IGF-II in the PI3K/Akt and MAPK signalling pathways. General and Comparative Endocrinology 157 116-124.
7. Coogan AN, O'Leary DM & O'Connor JJ 1999 P42/44 MAP kinase inhibitor PD98059 attenuates multiple forms of synaptic plasticity in rat dentate gyrus in vitro. Journal of Neurophysiology 81 103-110.
8. Fazakerley DJ,Holman GD,Marley A, James DE, Stockli J&Coster ACF 2010 Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes. Journal of Biological Chemistry 285 1653-1660.
9. Geetha T, Langlais P, Luo M, Mapes R, Lefort N, Chen SC, Mandarino LJ & Yi Z 2011 Label-free proteomic identification of endogenous, insulinstimulated interaction partners of insulin receptor substrate-1. Journal of the American Society for Mass Spectrometry 22 457-466.
10. Grassie ME, Moffat LD, Walsh MP & Macdonald JA 2011 The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1delta. Archives of Biochemistry and Biophysics 510 147-159.
11. Gual P, Le Marchand-Brustel Y & Tanti JF 2005 Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87 99-109.
12. Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM & Kobayashi M 2000 A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Molecular Endocrinology 14 783-794.
13. Ito M, Nakano T, Erdodi F & Hartshorne DJ 2004 Myosin phosphatase: structure, regulation and function. Molecular and Cellular Biochemistry 259 197-209.
14. Langlais P, Yi Z, Finlayson J, Luo M, Mapes R, De Filippis E, Meyer C, Plummer E, Tongchinsub P, Mattern M et al. 2011 Global IRS-1 phosphorylation analysis in insulin resistance. Diabetologia 54 2878-2889.
15. Lee TX, Packer MD, Huang J, Akhmametyeva EM, Kulp SK, Chen CS, Giovannini M, Jacob A, Welling DB & Chang LS 2009 Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. European Journal of Cancer 45 1709-1720.
16. Matsumura F & Hartshorne DJ 2008 Myosin phosphatase target subunit: many roles in cell function. Biochemical and Biophysical Research Communications 369 149-156.
17. Mothe I & Van Obberghen E 1996 Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. Journal of Biological Chemistry 271 11222-11227.
18. Okamoto R, Kato T, Mizoguchi A, Takahashi N, Nakakuki T, Mizutani H, Isaka N, Imanaka-Yoshida K, Kaibuchi K, Lu Z et al. 2006 Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart. Cell Signalling 18 1408-1416.
19. Porchia LM, Guerra M, Wang YC, Zhang Y, Espinosa AV, Shinohara M, Kulp SK, Kirschner LS, Saji M, Chen CS et al. 2007 2-Amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phe nyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase. Molecular Pharmacology 72 1124-1131.
20. Proud CG 2011 mTOR signalling in health and disease. Biochemical Society Transactions 39 431-436.
21. Ryder JW, Lau KS, Kamm KE & Stull JT 2007 Enhanced skeletal muscle contraction with myosin light chain phosphorylation by a calmodulinsensing kinase. Journal of Biological Chemistry 282 20447-20454.
22. Siddle K 2011 Signalling by insulin and IGF receptors: supporting acts and new players. Journal of Molecular Endocrinology 47 R1-R10.
23. Sun XJ & Liu F 2009 Phosphorylation of IRS proteins Yin-Yang regulation of insulin signaling. Vitamins and Hormones 80 351-387.
24. Tanti JF, Gremeaux T, van Obberghen E & Le Marchand-Brustel Y 1994 Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. Journal of Biological Chemistry 269 6051-6057.
25. Valverde AM, Mur C, Pons S, Alvarez AM, White MF, Kahn CR & BenitoM 2001 Association of insulin receptor substrate 1 (IRS-1) y895 with Grb-2 mediates the insulin signaling involved in IRS-1-deficient brown adipocyte mitogenesis. Molecular and Cellular Biology 21 2269-2280.
26. Venable CL, Frevert EU, Kim YB, Fischer BM, Kamatkar S, Neel BG & Kahn BB 2000 Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport orAkt/Protein kinaseBactivation. Journal of Biological Chemistry 275 18318-18326.
27. Virshup DM & Shenolikar S 2009 From promiscuity to precision: protein phosphatases get a makeover. Molecular Cell 33 537-545.